The Latest Breaking News from WST

Although West Pharmaceutical Services has underperformed the Dow over the past year, it has significantly outperformed in recent months, and analysts remain strongly bullish on the stock’s prospects.

Although West Pharmaceutical has underperformed relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

West Pharmaceutical Services, Inc. (NYSE:WST) shares are surging Thursday after the injectable pharmaceutical packaging and delivery systems company delivered a robust beat on its second-quarter 2025 earnings and revenue, while also significantly raising its full-year guidance.

West Pharmaceutical Services is expected to announce its second-quarter results later this month, with analysts projecting a marginal drop in its bottom line.